Symbol="DBVT"
AssetType="Common Stock"
Name="DBV Technologies"
Description="DBV Technologies SA, a clinical-stage biopharmaceutical company, is dedicated to the research and development of epicutaneous immunotherapy products. The company is headquartered in Montrouge, France."
CIK="1613780"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="177-181 AVENUE PIERRE BROSSOLETTE, MONTROUGE, FR"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="302327000"
EBITDA="-89996000"
PERatio="None"
PEGRatio="0"
BookValue="0.855"
DividendPerShare="0"
DividendYield="0"
EPS="-0.58"
RevenuePerShareTTM="0.028"
ProfitMargin="0"
OperatingMarginTTM="-19.47"
ReturnOnAssetsTTM="-0.254"
ReturnOnEquityTTM="-0.496"
RevenueTTM="5252000"
GrossProfitTTM="4844000"
DilutedEPSTTM="-0.58"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.496"
AnalystTargetPrice="5.11"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="28.15"
PriceToBookRatio="1.356"
EVToRevenue="-"
EVToEBITDA="-0.989"
Beta="1.145"
num_52WeekHigh="2.5"
num_52WeekLow="1.08"
num_50DayMovingAverage="1.742"
num_200DayMovingAverage="1.589"
SharesOutstanding="188095000"
DividendDate="None"
ExDividendDate="None"
symbol="DBVT"
open="1.49"
high="1.52"
low="1.49"
price="1.50"
volume="6716.00"
latest_trading_day="2023-08-18"
previous_close="1.51"
change="-0.01"
change_percent="-0.6623%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="15"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="85"
Volume_recent_avg="163224"
Change_recent_avg="-0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.59"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="85"
Aroon_momentum_negative="15"
image_negative_thumbnail_id_1="1122"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0155.jpeg"
image_negative_thumbnail_id_2="1163"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0197.jpeg"
image_neutral_thumbnail_id_1="530"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_neutral_thumbnail_id_2="565"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_positive_thumbnail_id_1="989"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0151.jpeg"
image_positive_thumbnail_id_2="986"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0148.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
